Merck (MRK) Tops Q4 EPS by 24c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
BMO Capital Reiterates Market Perform Rating on Merck (MRK) Following Earnings
February 3, 2022 7:46 AM ESTBMO Capital analyst Evan David Seigerman reiterated a Market Perform rating and $87.00 price target on Merck (NYSE: MRK), following the company's Q4 earnings report.
The analyst quotes: "Modest best (Rev +4%, Operating Income +5%). While there was an overall beat on revenues this largely came from... More
Cantor Fitzgerald Reiterates Merck (MRK) at Overweight on Earnings, Pipeline and Growth "Remains Underappreciated"
February 3, 2022 7:44 AM ESTCantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $107.00 price target on Merck (NYSE: MRK), following the company's Q4 earnings report.
The analyst quotes: "Post a 4Q21 sales and EPS beat, and ahead of a strong outlook for 2022, we are... More
